Vimarsana
Biggest News Aggregation in the World

Page 8 - Precision Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Precision Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Precision Diagnostics Today - Breaking & Trending Today

Catholic school Cristo Rey opens amid pandemic to serve students in Southeast San Diego - Vimarsana News

Catholic school Cristo Rey opens amid pandemic to serve students in Southeast San Diego

Cristo Rey San Diego High School will give low-income students a college preparatory education and work study jobs at San Diego companies.

Invivoscribe files sPMA with the FDA for use of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with Newly Diagnosed FLT3-ITD Positive AML - Vimarsana News

Invivoscribe files sPMA with the FDA for use of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with Newly Diagnosed FLT3-ITD Positive AML

SAN DIEGO, Oct. 24, 2022 /PRNewswire/ -- Invivoscribe is pleased to announce that they have filed a supplemental Pre-Market Approval (sPMA) submis...

Unlocking more information from liquid biopsies - Vimarsana News

Unlocking more information from liquid biopsies

Fred Hutch computational biologist Dr. Gavin Ha received an NIH New Innovator Award to develop new assays and computational methods that will allow him to mine cancer patient blood samples for new information that can improve diagnosis, treatment and disease monitoring.

QIAGEN N.V.: QIAGEN and Neuron23 Partner to Develop Next-Generation Sequencing Companion Diagnostic for Novel Parkinson's Disease Drug - Vimarsana News

QIAGEN N.V.: QIAGEN and Neuron23 Partner to Develop Next-Generation Sequencing Companion Diagnostic for Novel Parkinson's Disease Drug

Initial development and validation of clinical trial assay Next-generation sequencing (NGS) based assay targeting LRRK2 from blood samples Collaboration expands QIAGEN's NGS testing

Neuron23 and QIAGEN Announce Collaboration to Develop the First Next-Generation Sequencing Companion Diagnostic for Novel Parkinson's Disease Drug - Vimarsana News

Neuron23 and QIAGEN Announce Collaboration to Develop the First Next-Generation Sequencing Companion Diagnostic for Novel Parkinson's Disease Drug

/PRNewswire/ -- Neuron23™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and...